30 April 2026

ACCELER8 VENTURES PLC

 ("AC8" or the "Company")

Full Year Results for the period ended 31 December 2025

Acceler8 Ventures Plc (LSE: AC8) has today published its Annual Report and Financial Statements for the period ended 31 December 2025 (the "Annual Report").

In accordance with UK Listing Rule 6.4.1 copies of the Annual Report have been submitted to the FCA and will shortly be available to view on the Company's website at https://acceler8.ventures and for inspection from the National Storage Mechanism at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

LEI: 2138004B1HKZP1OR2C72

Enquiries

CHAIRMAN'S STATEMENT

I am pleased to present the financial results for Acceler8 Ventures Plc ("AC8", the "Company") and its subsidiary (together the "Group") for the year ended 31 December 2025.

During the year and post year end we remained focused on executing our strategy, and I am delighted that on 8 April 2026 we were able to announce the proposed transaction with Intuitive Investments Group Plc ("IIG") (the "Proposed Transaction").  The independent directors of IIG currently intend that they would recommend the possible offer, and AC8 has received irrevocable undertakings to support the offer from shareholders owing c.25% of IIG's current share capital.  The tie up with IIG and its associated primary investment Hui10 Inc. ("Hui10"), is exactly the type of opportunity that we have been seeking out since listing AC8 in 2021 and we will be making the requisite updates to shareholders in due course.

I would like to thank our new subscribers to our recently raised convertible loan notes which closed in August 2025 and most recently, April 2026.  With that support, we are well capitalised and remain ideally positioned to continue to execute our strategy as we work towards completion of the Proposed Transaction.

David Williams

Chairman

29 April 2026

REPORT OF THE DIRECTORS

The Directors of the Company present their report for the year ended 31 December 2025.

PRINCIPAL ACTIVITY AND BUSINESS REVIEW

For the financial year ended 31 December 2025, the Group and Company's principal activities were that of a holding group and company, respectively.

The Company was incorporated for the purpose of identifying suitable acquisition opportunities in accordance with the Company's investment and acquisition strategy with a view to creating shareholder value. The Company retains a flexible investment and acquisition strategy which will, subject to appropriate levels of due diligence, enable it to deploy capital in target companies by way of minority or majority investments, or full acquisitions where it is in the interests of shareholders to do so. This will include transactions with target companies located in the UK and internationally, including but not limited to, Europe, and the Asia Pacific region.  It is anticipated by the Directors that acquisition opportunities could be with private companies, other listed business, or via the acquisition of divisional or non-core carve outs. The Company's strategic aim is to drive shareholder value through the acquisition of target companies in certain sectors where the Directors believe there to be sustainable growth opportunities both organically, and through acquisition. Particular sectors of focus include gaming, media and entertainment, software and technology, industrials and business services. While the Company retains sector flexibility regarding its initial acquisition, it is intended that subsequent investments and acquisitions will be of complementary businesses to that of the initial acquisition. Where target companies are acquired, the Directors and incoming management teams will seek to drive operational improvements and best practice to unlock revenue and cost synergies.

The Directors will look to identify opportunities in line with the following parameters:

It is possible the Board may consider acquisitions that do not conform to all of the above framework.  However, in all cases, the Company's strategic aim is to drive shareholder value through the acquisition of target companies in certain sectors where the Directors believe there to be sustainable growth opportunities both organically, and through acquisition. The Company is seeking fundamentally sound assets, where tangible opportunities exist to drive strategic, operational and performance improvements.

On 29 August 2025, the Company announced that it had successfully raised £380,000 through the issue of unsecured convertible loan notes (the "2025 Notes") to support working capital requirements in pursuit of an initial transaction.  The 2025 Notes have an interest rate of 8% per annum that is accrued daily and compounded annually.  Conversion of the 2025 Notes into ordinary shares of the Company is automatic, and immediately prior to completion of an initial transaction or on the third anniversary of issue if no initial transaction occurs.  The conversion price is the lower of £1.00 per share, and a 30% discount to the prevailing share price (initial transaction price or 20-day VWAP at the third anniversary of issue).

Subsequent to the year ended 31 December 2025, on 8 April 2026, the Company announced the Proposed Transaction with IIG.  Under the Proposed Transaction, which if completed, would constitute an initial transaction under UK Listing Rule 13.4 and reverse takeover under the Takeover Code, it is proposed that the enlarged group's shares would be listed on the Equity Shares (Commercial Companies) category of the Official List maintained by the Financial Conduct Authority.  The Proposed Transaction values IIG at approximately £600 million on a fully diluted basis based on the closing price per AC8 share of 80 pence on 7 April 2026.  AC8 shareholders are expected to hold 0.99 per cent. of the enlarged group share capital at admission to trading on the LSE's main market (after the effect of a bonus issue of ordinary shares to AC8 shareholders and the conversion of all outstanding convertible loan notes).

On 21 April 2026, the Company announced that it had successfully raised £1 million through the proposed issue of unsecured convertible loan notes (the "2026 Notes") to support working capital requirements in connection with the Proposed Transaction.  The 2026 Notes have an interest rate of 8% per annum that is accrued daily and compounded annually.  Conversion of the 2026 Notes into ordinary shares of the Company is automatic, and immediately prior to completion of an initial transaction or on the third anniversary of issue if no initial transaction occurs.  The conversion price on the basis of completion of the Proposed Transaction is 34 pence per share, otherwise it will be at a 30% discount to the prevailing share price of an alternative initial transaction price or 20-day VWAP at the third anniversary of issue.

At the same time, the Company also announced a proposed amendment to the 2025 Notes to adjust the conversion price per share to 28 pence on the basis the Proposed Transaction completes.

RESULTS

During the year, the Group recorded a loss of £167,089 (2024: loss of £160,480) and the loss per share was £0.22 (2024: loss per share of £0.21).  This reflects the moderate monthly operating expenses of the Group, combined with the unwinding of the discount on the debt host liability component of the 2025 Notes of £24,044 (2024: nil) offset by changes in fair value of the embedded derivative liability of £29,545 (2024: nil). The Group and Company had cash reserves at the end of the year of £209,224 (2024: £113) and net liabilities of £213,140 (2024: £46,364) and £213,207 (2024: £46,431) respectively following issue of the 2025 Notes.

The 2025 Notes are a hybrid financial instrument whereby a debt host liability component and embedded derivative liability component was determined at initial recognition.  The fair value of the embedded derivative liability is determined first and the residual amount is assigned to the debt host liability.  Thereafter the debt host liability is valued using the amortised cost basis.  The carrying value of the 2025 Notes as at 31 December 2025 was £374,499 (2024: nil).  Refer to note 14 for more details on the 2025 Notes.

DIVIDENDS

At this point in the Group's development, it does not anticipate declaring any dividends in the foreseeable future. As such, the Directors do not recommend the payment of a dividend for the year.

FUTURE DEVELOPMENTS

The Directors expect to continue to execute the Group's strategy in sourcing and assessing acquisition and investment opportunities across its stated sectors of focus.

KEY PERFORMANCE INDICATORS

The Board continues to focus on maximising shareholder value through pursuing its acquisition strategy.

As such, the Board will identify and develop appropriate key performance indicators after an acquisition has been completed.

GOING CONCERN

The Group and Company's unaudited cash balance as at 29 April 2026 was £1,055,942.  As a result, the Directors believe the Company has sufficient working capital to fund all budgeted "as incurred" costs associated with pursuing the Proposed Transaction (as explained in note 22), including in the event that the transaction does not complete. However, in the event of an abort, the Company would likely require recapitalisation to continue operating as an acquisition vehicle thereafter.

As part of the enlarged group in the event the Proposed Transaction completes, the company will have sufficient funds to execute operations.  In the event an abort occurred, successful recapitalisation, including the timing and amount of such, are matters that are not entirely within the control of the Directors, and thus represent material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern.

Notwithstanding the above, the Directors, therefore, have made an informed judgement at the time of approving the financial statements, that there is a reasonable expectation that, on successful completion of the Proposed Transaction, the Group and Company will have adequate resources to continue in operational existence for the foreseeable future.  As a result, the Directors have adopted the going concern basis of accounting in preparing the annual financial statements. The accompanying financial statements do not include any adjustments that would be required if they were not prepared on a going concern basis.

RISK MANAGEMENT

In order to execute the Group's strategy, the Company and its subsidiaries will be exposed to both financial and non-financial risks. The Board has overall responsibility for the Group's risk management and it is the Board's role to consider whether those risks identified by management are acceptable within the Group's strategy and risk appetite. The Board therefore periodically reviews the principal risks and considers how effective and appropriate the controls that management has in place to mitigate the risk exposure are and will make recommendations to management accordingly.

As the Company had not completed an investment or acquisition in the year, it has limited financial statements and/or historical financial data, and limited trading history. As such, the Company during the year was subject to the risks and uncertainties associated with an early-stage acquisition company, including the risk that the Company will not achieve its investment objectives and that the value of any investment or acquisition could decline and may result in the partial or complete loss of capital invested. The past performance of investee companies or assets managed by the Directors will not necessarily be a guide to future business, results of operations, financial condition or prospects of the Company.

In order to mitigate against these risks, the Directors continue to undertake thorough due diligence on investment opportunities and acquisition targets, to a level considered reasonable and appropriate by the Company on a case-by-case basis, including the potential commissioning of third-party specialist reports as appropriate. Following completion of any investment or acquisition, it is intended that any investments or assets will be overseen by the Directors and assisted by the Company's professional advisers.

Financial Risk Management

The Directors consider the Group to be exposed to the following financial risks:

Given the relatively small size and operation of the Group in the year, the Directors have not delegated the responsibility of risk monitoring to a sub-committee of the Board, but closely monitor the risks on a periodic basis. The Directors consider their exposure in the financial year to have been low. Refer to note 15 for assessment of the risks arising from financial instruments.

Non-financial Risk Management

The non-financial risk factors for the year ended 31 December 2025 did not materially change from those set out in AC8's Prospectus dated 14 July 2021.

GREENHOUSE GAS EMISSIONS, ENERGY CONSUMPTION AND ENERGY EFFICIENCY

As the Company has not completed its first acquisition and has only two Directors, limited travel and no premises, the Directors do not consider any disclosure under the Task Force on Climate-related Financial Disclosures is required at this juncture, however the Company will continue to review this position as it executes its investment and acquisition strategy. 

POLITICAL CONTRIBUTIONS

The Company has made no political contributions during the year.

CHARITABLE DONATIONS

The Company has made no charitable donations during the year.

POST BALANCE SHEET EVENTS

Refer to note 22 of the consolidated financial statements.

SHARE CAPITAL

Details of the Company's share capital is set out in note 16.  The Company's share capital consists of one class of ordinary share, which does not carry rights to fixed income. As at 31 December 2025, there were 750,000 ordinary shares of 1p par value each in issue.

SIGNIFICANT SHAREHOLDERS

As at 15 April 2026, the Company had been advised of the following notifiable interests (whether directly or indirectly held) in voting rights.

As at 15 April 2026, the Directors in aggregate held 375,000 ordinary shares, which represents 50.0 per cent. of the Company's issued share capital.

COMPANY DIRECTORS

The Directors during the year and summaries of their experience are set out below.

David Williams Non-Executive Chairman (aged 73)

David has over 40 years' experience in investment markets, serving as Chairman in executive and non-executive capacities for a number of public and private companies. He has overseen the development of these companies, raising in excess of £1 billion of capital to support both organic and acquisitive growth initiatives.

David was the original founder of Marwyn Capital LLP, the award-winning investment management company. David was also formerly Chairman of Entertainment One Ltd. (LSE: ETO), Zetar plc, and Oxford BioDynamics Plc (AIM: OBD), and Non-Executive Director of Breedon Group plc (LSE: BREE). He currently serves as Non-executive Chairman of Main Market listed Red Capital Plc (LSE: RED) and Bay Capital Plc (LSE: BAY).

Giles Willits Non-Executive Director (age 59)

Giles has more than 22 years' experience in senior leadership and financial roles in multiple household name businesses. He is Chief Executive Officer of Intuitive Investments Group plc (LSE: IIG), an investment company concentrating on fast growing and/or high potential technology and life sciences businesses. Prior to this, Giles was Chief Financial Officer and board director of IG Design Group plc (AIM: IGR), the world's largest consumer gift packaging organisation.

Previously Giles was Chief Financial Officer of Entertainment One Ltd. (LSE: ETO), having joined prior to its admission to trading on AIM in 2007, during which time the business grew organically and through acquisitions to a market capitalisation of over £1 billion, becoming a FTSE250 premium listed organisation. He was also formerly Director of Group Finance at J Sainsbury plc and qualified as a chartered accountant at PricewaterhouseCoopers.

During his extensive career, Giles has completed numerous corporate acquisitions as part of buy-and-build strategies, acquiring private and publicly listed companies, stepping companies up from AIM to the Main Market, as well as leading on equity and debt financings in support of organic growth and acquisition activity.

The Directors who held office during the year and their beneficial interest in the share capital of the Company at 31 December 2025 were as follows:

DIRECTORS REMUNERATION

The Chairman and Non-Executive Director are each entitled to fees of £20,000 each per annum for their respective roles within the Company, as per their service agreements entered into on 13 July 2021.  During the year, £1,333 of Director fees were accrued (2024: £10,339). There are no other benefits paid to Directors outside of their service fees, save for ordinary course reimbursable expenses properly incurred in the performing of their duties as Directors. The Company does not operate a pension scheme. 

In addition to the Directors' fee entitlements outlined above, the Directors are also participants in the Subco Incentive Scheme as detailed below. 

SUBCO INCENTIVE SCHEME

The Directors believe that the success of the Company will depend to a high degree on the future performance of key employees and advisers in executing and supporting the Company's growth strategy. The Company has therefore established equity-based incentive arrangements which are, and will continue to be, an important means of retaining, attracting and motivating key employees, consultants and advisers, and also for aligning the interests of the Directors with those of shareholders.

On 27 May 2021, the Group created a new Subco Incentive Scheme within its wholly owned subsidiary Acceler8 Ventures Subco Limited. Under the terms of the Subco Incentive Scheme, scheme participants are only rewarded if a predetermined level of shareholder value is created over a three to five year period or upon a change of control of the Company or Subco (whichever occurs first), calculated on a formula basis by reference to the growth in market capitalisation of the Company, following adjustments for the issue of any new ordinary shares and taking into account dividends and capital returns ("Shareholder Value"), realised by the exercise by the beneficiaries of a put option in respect of their shares in Subco and satisfied either in cash or by the issue of new ordinary shares at the election of the Company.

Under these arrangements in place, participants are entitled up to 15 per cent. of the Shareholder Value created, subject to such Shareholder Value having increased by at least 12.5 per cent. per annum compounded over a period of between three and five years from Admission, or following a change of control of the Company or Subco.

In order to implement the Subco Incentive Scheme, the Company as sole shareholder of Subco, approved the creation of a new share class in Subco (the "B Shares"). At the same time the Subco's existing ordinary shares were redesignated A Shares. The B Shares do not have voting or dividend rights.

On 27 May 2021, David Williams, Chairman of the Company, Giles Willits, a Non-Executive Director of the Company, and Kathleen Long and Anthony Morris, Directors of Tessera Investment Management Limited ("Tessera"), became the first participants in the Subco Incentive Scheme ("Founder Participants"), and as such, the proportion of Shareholder Value attaching to the Subco Incentive Scheme is 2.9 per cent. of a total cap of 15 per cent.

The Founder Participants and their respective holdings are outlined below.

As announced on 8 April 2026, the Company intends, on completion of the Proposed Transaction, to void the Subco Incentive Scheme with no payout to participants.

CORPORATE GOVERNANCE

As a Jersey company and a Shell Company (Equity Shares) on the London Stock Exchange, under the new UK Listing Rules ("UKLR"), the Company is not required to comply with the provisions of the UK Corporate Governance Code 2018.  Furthermore, there is no applicable regime of corporate governance to which the directors of a Jersey company must adhere over and above the general fiduciary duties and duties of care, skill and diligence imposed on such directors under Jersey law. Notwithstanding this, the Directors are committed to maintaining high standards of corporate governance and will be responsible for carrying out the Company's objectives and implementing its business strategy.

All investment, acquisition, divestment and other strategic decisions are considered and determined by the Board. At present, the Board reviews investment and acquisition opportunities on an as required basis, and meets regularly with its Strategic Advisor to discuss possible inorganic growth opportunities, as well as monitor deal flow and investment and acquisitions in progress, and review the Company's strategy to ensure that it remains aligned to the delivery of shareholder value. Those investment and acquisition opportunities that are assessed by the Board (with support from its Strategic Advisor) are considered in light of the investment and acquisition criteria as detailed in the Company's Admission Document. In addition, as part of the investment and acquisition screening process, the Company will augment Board and Strategic Advisor capability on a case by case basis as required with industry and operating partner input, where deep domain expertise can be accessed. The Board provides leadership within a framework of prudent and effective controls. The Board has established the corporate governance values of the Company and has overall responsibility for setting the Company's strategic aims, defining the business plan and strategy and managing the financial and operational resources of the Company.

In this regard, the Board, so far as is practicable given the Company's size and stage of its development, has voluntarily adopted the 2023 QCA Code as its chosen corporate governance framework. There are certain provisions of the QCA Code which the Company will not adhere to currently, and their adoption will be delayed until such time as the Directors believe it is appropriate to do so. It is anticipated that this will occur concurrently with the Company's first material investment or acquisition.  Details on how the Company applies the ten principles of the 2023 QCA Code are set out below and on the Company's website at www.acceler8.ventures.      

ROLE OF THE BOARD

The Board is responsible for the management of the business of the Group, setting the strategic direction of the Group and establishing the policies of the Group. It is the Directors' responsibility to oversee the financial position of the Group and monitor the business and affairs of the Group, on behalf of the shareholders, to whom they are accountable. The primary duty of the Directors is to act in the best interests of the Group and Company at all times. The Board also addresses issues relating to internal control and the Group's approach to risk management and has formally adopted an anti-corruption and bribery policy.

The Group does not have a separate investing committee and therefore the Board as a whole will be responsible for sourcing acquisitions and ensuring that opportunities are in conformity with the Group's strategy.

The Group holds four formal Board meetings a year, with unscheduled meetings as matters arise which require the attention of the Board.  The Directors commit sufficient time to discharge their duties as directors of the Company, and meet the expectations of their respective roles.  There is no maximum time commitment specified, and outside of formal board meetings, the Directors devote additional time to the Company in respect of preparatory work and ad hoc meetings, particularly when the Company undergoes increased corporate activity.

During the year, each Director attended all four of the formally scheduled quarterly Board meetings of the Company.

The Group has not adopted a formal policy on diversity; however, it is committed to a culture of equal opportunities for all, regardless of age, race or gender.  The Board is currently made up of two male directors and there are no other employees in the Company.

INTERNAL CONTROLS

The Board acknowledges its responsibility for establishing and monitoring the Group's systems of internal control. Although no system of internal control can provide absolute assurance against material misstatement or loss, the Group's systems are designed to provide the Directors with reasonable assurance that problems can be identified on a timely basis and dealt with appropriately.

The Group maintains an appropriate process for financial reporting. The annual budget is reviewed and approved by the Board before being formally adopted.

Other key procedures that have been established and which are designed to provide effective control are as follows:

Management structure - The Board meets regularly on a formal and informal basis to discuss all issues affecting the Group.

Investment appraisal - The Group has a robust framework for investment appraisal and approval is required by the Board, where appropriate.

Share dealing and inside information - the Company has adopted a share dealing code regulating trading and confidentiality of inside information for the Directors and other persons discharging managerial responsibilities (and their persons closely associated) which contains provisions appropriate for a company whose shares are admitted to trading on the Official List (particularly relating to dealing during closed periods which will be in line with the Market Abuse Regulation). The Company takes all reasonable steps to ensure compliance by the Directors and any relevant employees with the terms of that share dealing code.

The Board reviews the effectiveness of the systems of internal control and considers the major business risks and the control environment. No significant deficiencies have come to light during the year and no weaknesses in internal financial control have resulted in any material losses, or contingencies which would require disclosure, as recommended by the guidance for Directors on reporting on internal financial control.

The Directors are focused on careful management of the Group's cash and financial resources through Board level approvals. At such time that the Group completes an acquisition, the Directors anticipate that the Group's financial position and prospects procedures regime will be updated and expanded as necessary to cater for the nature of the Group's business following completion of its inaugural investment or acquisition.

EXTERNAL ADVISERS

The Board accessed the following external advisers during the year and post the year end for on going business as usual matters as well as specialist advice in relation to the Company's Proposed Transaction announced on 8 April 2026, and its related interactions with the FCA and the Takeover Panel:

Mayer Brown International LLP and Ogier (Jersey) LLP - legal

Tessera Investment Management Limited - strategic advice, capital markets and M&A

Joh. Berenberg, Gossler & Co. KG, London Branch - financial advisor and Rule 3 advisor

JTC (Jersey) Limited - company secretarial, governance and regulatory filings

CONFLICTS OF INTEREST

A Director has a duty to avoid a situation in which he or she has, or can have, a direct or indirect interest that conflicts, or possibly may conflict, with the interests of the Company. The Board has satisfied itself that it has maintained suitable protocols to ensure it appropriately managed any perceived or actual conflicts of interest where the Directors have appointments on the Boards of, or relationships with, companies outside the Company. Furthermore, the Board requires Directors to declare all appointments and other situations which could result in a possible conflict of interest, and therefore believes it has a robust framework to deal with any conflict of interest should it arise.

DISCLOSURE OF INFORMATION TO THE AUDITOR

So far as the Directors are aware, there is no relevant audit information of which the Group and Company's independent auditor is unaware, and each Director has taken all the steps that he ought to have taken as a Director in order to make himself aware of any relevant audit information and to establish that the Group and Company's independent auditor is aware of that information.

The Directors confirm to the best of their knowledge that:

INDEPENDENT AUDITOR

The auditor, MHA, previously traded through the legal entity MacIntyre Hudson LLP. In response to regulatory changes, MacIntyre Hudson LLP ceased to hold an audit registration with the engagement transitioning to MHA Audit Services LLP.  The independent auditor, MHA, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD

David Williams

Chairman

29 April 2026

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The Directors are responsible for preparing the Directors' report and the financial statements in accordance with applicable law and regulations.

Jersey Company law requires the directors to prepare financial statements for each financial year. Under that law the Directors have elected to prepare the consolidated financial statements in accordance with International Financial Reporting Standards as adopted by the United Kingdom ("IFRS") and the Company financial statements in accordance with FRS 101 "Reduced disclosure Framework", the Financial Reporting Standard applicable in the UK. Under company law, the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Group and Company and of the profit or loss of the Group for that year.

In preparing these financial statements, the Directors are required to:

The Directors are responsible for keeping proper accounting records that are sufficient to show and explain the Group and Company's transactions and disclose with reasonable accuracy at any time the financial position of the Group and Company and enable them to ensure that the financial statements comply with the Companies (Jersey) Law 1991. They are also responsible for safeguarding the assets of the Group and Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The maintenance and integrity of the Group's website is the responsibility of the Directors. The work carried out by the independent auditors does not involve the consideration of these matters and, accordingly, the independent auditors accept no responsibility for any changes that may have occurred in the accounts since they were initially presented on the website. Legislation in Jersey governing the preparation and dissemination of the accounts and the other information included in annual reports may differ from legislation in other jurisdictions.

Consolidated statement of comprehensive income

For the year ended 31 December 2025

All activities in both the current and the prior period relate to continuing operations.

The notes below form part of these consolidated financial statements.

Consolidated statement of financial position

As at 31 December 2025

The consolidated financial statements were approved and authorised for issue by the Board on 29 April 2026 and were signed on its behalf by:

David Williams

Chairman

The notes below form part of these consolidated financial statements.

Consolidated statement of changes in equity

For the year ended 31 December 2025

The notes below form part of these consolidated financial statements.

Consolidated statement of cash flows

For the year ended 31 December 2025

Please refer to note 20 for a reconciliation of changes in liabilities arising from financing activities.

The notes below form part of these consolidated financial statements.

Notes forming part of the consolidated financial statements

For the year ended 31 December 2025

The Company is a public limited company incorporated and domiciled in Jersey, whose shares are publicly traded on the London Stock Exchange as a Shell Company (Equity Shares). The Company is the parent company of Acceler8 Ventures Subco Limited (a private company under the laws of Jersey with registered number 134587), and together form the "Group".

The address of its registered office is 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey.

The Group has been incorporated for the purpose of identifying suitable acquisition opportunities in accordance with the Group's investment and acquisition strategy with a view to creating shareholder value. The Group will retain a flexible investment and acquisition strategy which will, subject to appropriate levels of due diligence, enable it to deploy capital in target companies by way of minority or majority investments, or full acquisitions where it is in the interests of shareholders to do so. This will include transactions with target companies located in the UK and internationally.

The accounting policies set out below have, unless otherwise stated, been applied consistently to all periods presented in these consolidated financial statements.

The principal policies adopted in the preparation of the consolidated financial statements are as follows: 

(a) Basis of preparation

These consolidated financial statements have been prepared in accordance with the requirements of International Financial Reporting Standards as adopted by the United Kingdom ("IFRS") and the requirements of the Companies (Jersey) Law 1991.

The consolidated financial statements are prepared on the historical cost basis.

The comparative figures presented cover the year ended to 31 December 2024.

(b) Basis of consolidation

The consolidated financial statements present the results of the Company and its subsidiaries (the "Group") as if they formed a single entity. Intercompany transactions and balances between Group companies are therefore eliminated in full.

Where the Group has control over a Company, it is classified as a subsidiary. The Group controls a Company if all three of the following elements are present: power over the Company, exposure to variable returns from the Company, and the ability of the Group to use its power to affect those variable returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.

The consolidated financial statements incorporate the results of business combinations using the acquisition method. In the consolidated statement of financial position, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The acquisition related costs are included in the consolidated statement of comprehensive income on an accruals basis. The results of acquired operations are included in the consolidated statement of comprehensive income from the date on which control is obtained.

(c) Functional and presentational currency

The Group's functional and presentational currency for these financial statements is the pound sterling.

(d) Going concern

The Group and Company's unaudited cash balance as at 29 April 2026 was £1,055,942.  As a result, the Directors believe the Company has sufficient working capital to fund all budgeted "as incurred" costs associated with pursuing the Proposed Transaction (as explained in note 22), including in the event that the transaction does not complete. However, in the event of an abort, the Company would likely require recapitalisation to continue operating as an acquisition vehicle thereafter.

As part of the enlarged group in the event the Proposed Transaction completes, the company will have sufficient funds to execute operations.  In the event an abort occurred, successful recapitalisation, including the timing and amount of such, are matters that are not entirely within the control of the Directors, and thus represent material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern.

Notwithstanding the above, the Directors, therefore, have made an informed judgement at the time of approving the financial statements, that there is a reasonable expectation that, on successful completion of the Proposed Transaction, the Group and Company will have adequate resources to continue in operational existence for the foreseeable future.  As a result, the Directors have adopted the going concern basis of accounting in preparing the annual financial statements. The accompanying financial statements do not include any adjustments that would be required if they were not prepared on a going concern basis.

(e) Interest receivable

Interest receivable is recognised on a time-proportion basis using the effective interest rate method.

(f) Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognised in the income statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity, in which case it is recognised in other comprehensive income or equity respectively.

Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates and laws enacted or substantively enacted at the statement of financial position date.

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amount of assets and liabilities, using tax rates and laws enacted or substantively enacted at the statement of financial position date.

A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available against which the temporary difference can be utilised.

(g)  Equity

Equity comprises share capital, share premium, capital redemption reserve, share-based payment reserve, non-controlling interests and retained deficit.

Share capital is measured at par value.

Please see note 17 for further details on reserves.

(h)  Financial instruments

Financial instruments are measured as set out below. Financial instruments carried on the statement of financial position include cash and cash equivalents, other receivables, accruals and convertible loan notes.

Financial assets

Cash and cash equivalents

Cash and cash equivalents comprise cash balances and short-term deposits with an original maturity of three months or less from inception, held for meeting short term commitments.  Cash and cash equivalents are carried in the statement of financial position at cost.

Other receivables

Other receivables comprise interest receivable on cash balances and are carried in the statement of financial position at amortised cost less provision for expected credit losses.

Financial liabilities

Fair value through profit or loss

This category comprises the embedded derivative component of the 2025 Notes as outlined in note 14.  The embedded derivative is carried in the consolidated statement of financial position at fair value with changes in fair value recognised in the consolidated statement of comprehensive income.

Other financial liabilities

This category includes accruals and the debt host liability component of the 2025 Notes which are measured at amortised cost using the effective interest method.  Refer to note 14 for further detail on the  2025 Notes.

(i)  Share-based payments

The Group operates an equity-settled share-based payment plan. The fair value of the employee services received in exchange for the grant of options is recognised as an expense over the vesting period, based on the Group's estimate of awards that will eventually vest, with a corresponding increase in equity as a share-based payment reserve.

This plan includes market-based vesting conditions for which the fair value at grant date reflects and are therefore not subsequently revisited. The fair value is determined using a binomial model.

(j)  Related party transactions

The Group discloses transactions with related parties which are not wholly owned with the same group. It does not disclose transactions with members of the same group that are wholly owned.

(k)  Accounting standards issued

The following amendments to standards were issued and adopted in the year, with no material impact on the financial statements (all effective for annual periods beginning on or after 1 January 2025):

         There were no other new accounting standards issued that have been adopted in the year.

(l)  Standards in issue but not yet effective

At the date of authorisation of these financial statements there were amendments to standards which were in issue, but which were not yet effective, and which have not been applied. The principal ones are detailed below.

The Directors do not expect the adoption of these amendments to standards to have a material impact on the financial statements, with the exception of presentational changes as a result of IFRS 18 Presentation and Disclosure in Financial Statements. Given that IFRS 18 is not effective until the period beginning 1 January 2027, the impact assessment of this standard is ongoing and will be considered further in the coming years.

          Effective for periods beginning on or after 1 January 2026:

          Effective for periods beginning on or after 1 January 2027:

In preparing the consolidated financial statements, the Directors have to make judgments on how to apply the Group's accounting policies and make estimates about the future.  Actual results may vary from the estimates used to produce these financial statements.

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Significant items subject to such estimates and judgements include:

Valuation of derivative financial instruments

The conversion option on the 2025 Notes issued by the Group is an embedded derivative which was valued using a binomial lattice option model.  This methodology of determining fair value is reliant upon estimates including the Company's future share price volatility and probability of an early conversion following an initial transaction.  The sensitivity of the valuation to these estimates is considered in note 14.

The Company Directors are considered the only key management personnel and their remuneration was as follows:

Deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which the deductible temporary differences and carry forward tax losses/credits can be utilised. Accordingly, the Group has not recognised deferred tax assets in respect of deductible temporary differences and carry forward tax losses as at 31 December 2025 and 31 December 2024 respectively, as it is not probable at year end that relevant taxable profits will be available in future based on the current activities of the Group as a holding group. There are no expiry dates on these tax losses as at the year end. The unrecognised deferred tax asset is summarised below:

Earnings per share ("EPS") is calculated by dividing the loss after tax for the year by the weighted average number of shares in issue for the year, these figures being as follows:

The basic and diluted loss per share for the years ended 31 December 2025 and 31 December 2024 are the same as the result for both years were a loss, and therefore the Subco Incentive Scheme share options (note 19) and the convertible loan note options (note 14) would be anti-dilutive, however they may become dilutive in future periods.  Therefore, the dilutive loss per share is considered as the same as the basic loss per share. 

The Company directly owns the ordinary share capital of its subsidiary undertakings as set out below:

The address of the registered office of Acceler8 Ventures Subco Limited (the "Subco") is 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey. The Subco was incorporated on 25 March 2021.

The A ordinary shares have full voting rights, full rights to participate in a dividend and full rights to participate in a distribution of capital.  The B ordinary shares have been issued pursuant to the Company's Subco Incentive Scheme.

On 28 August 2025, the Company raised £380,000 through the issue of unsecured convertible loan notes (the "2025 Notes") at an interest rate of 8% per annum, accrued daily and compounded annually.  Conversion of the 2025 Notes into ordinary shares of the Company is automatic, and immediately prior to completion of an initial transaction (having the meaning set out in UKLR 13.4.1) or on the third anniversary of issue if no initial transaction occurs.  The conversion price is the lower of £1.00 per share, and a 30% discount to the prevailing share price (initial transaction price or 20-day VWAP at the third anniversary of issue).

The 2025 Notes are a hybrid financial instrument whereby a debt host liability component and embedded derivative liability component was determined at initial recognition.  The conversion option did not satisfy the fixed for fixed equity criterion as the number of shares issued is variable and based on the future share price of the Company. The fair value of the embedded derivative liability is determined first and the residual amount is assigned to the debt host liability. 

The debt host liability is accounted for using the amortised cost basis with an effective interest rate of 41.95%. The effective interest rate is the discount rate that discounts the debt host liability's estimated future contractual cashflows over its expected life to the initial carrying amount of the debt host. 

There were no directly attributable transaction costs associated with the issue of the 2025 Notes.

Fair value measurement

The initial recognition of the embedded derivative conversion feature has been recognised as a liability on the balance sheet with any changes to the fair value of the derivative recognised in the income statement. It has been fair valued using a binomial lattice valuation model which incorporate assumptions including share price, expected volatility, risk-free interest rate, expected term, coupon, and the probability and timing of conversion.  Changes in these assumptions affect the reported fair value of the embedded derivative.  The binomial lattice valuation model was used to value the embedded derivative on issue date (28 August 2025) and at year end 31 December 2025.  The assumptions for the valuation of the embedded derivative at initial recognition and year end are shown below:

The expected volatility was estimated by reference to the historical 3-year volatility of the Company.

The valuation of the embedded derivative liability is prepared with the assistance of the Directors and their advisors.  The valuation methodology, significant assumptions and resulting fair value are reviewed and approved at each reporting date.  Changes in fair value hierarchy classification, valuation techniques and key assumptions are considered as part of the period-end financial reporting process. 

The fair value of the embedded derivative at initial recognition was £212,641.  As the proceeds received from the 2025 Notes was £380,000, the residual allocated to the debt host liability was £167,359.

The fair value of the embedded derivative is a level 3 recurring fair value measurement.  A reconciliation of the opening and closing fair value balance is provided below:

The valuation technique and significant unobservable inputs used in determining the fair value measurement as well as the inter-relationship between key unobservable inputs and fair value is detailed in the table below.

Sensitivity analysis

The sensitivity analysis has been prepared by recalculating the fair value of the embedded derivative liability at the reporting date using reasonably possible alternative assumptions for each significant unobservable input, while holding all other assumptions constant.  The revised fair values derived from those alternative assumptions have then been compared with the base case fair value at the reporting date.

Reasonable possible alternative assumptions at the reporting date would have a significant effect on the fair value of the embedded derivative liability as follows:

A 30% increase / decrease to the expected volatility of the Company's share price results in a variance of £21,021 / £19,508 in the fair value of the embedded derivative liability respectively.

A 30% increase / decrease to the probability of an initial transaction results in a variance of £15,462 / £18,706 in the fair value of the embedded derivative liability respectively.

The Group is exposed to the following financial risks:

The Group is exposed to risks that arise from its use of financial instruments.  This note describes the Group's objectives, policies and processes for managing those risks and the methods used to measure them.  Further quantitative information in respect of these risks is presented throughout these financial statements.  There have been no substantive changes in the Group's exposure to financial instrument risks, its objectives, policies and processes for managing those risks or the methods used to measure them from previous periods unless otherwise stated in this note.

(i)            Principal financial instruments

The principal financial instruments used by the Group, from which financial instrument risk arises comprise cash and cash equivalents, other receivables, accruals, and convertible loan notes.

(ii)           Financial instruments by category

Financial assets

Financial liabilities

(iii)         Financial risk factors

Credit risk

The Group's credit risk is wholly attributable to its cash balance. All cash balances are held at a reputable bank in Jersey. A cash balance becomes credit-impaired only when there is objective evidence that the bank counterparty may not repay the full amount or access to the funds has been impaired.  The credit risk from the Group's cash balance is deemed to be low due to the nature and size of the balance held.

Liquidity risk

Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due.

The Group's approach to liquidity risk is to ensure that sufficient liquidity is available to meet foreseeable requirements and to invest funds securely and profitably, where those funds are available to do so.  As noted in the Report of the Directors, the Group raised £380,000 fixed rate unsecured convertible loan notes during the year to support working capital requirements in pursuit of an initial transaction.

The following table details the contractual maturity of undiscounted financial liabilities based on the dates the liabilities are due to be settled:

Financial liabilities:

Fair value measurement

The fair value measurement of the Group's financial instruments utilises market observable inputs and data as far as possible.  Inputs used in determining fair value measurements are categorised into different levels based on how observable the inputs used in the valuation technique utilised are (the "fair value hierarchy"):

The classification of an item into the above levels is based on the lowest level of the inputs used that has a significant effect on the fair value measurement of the item. 

The carrying value of all other financial assets and financial liabilities approximates to their fair value.

Information relating to the basis of determination of the level 3 fair value for the convertible loan note embedded derivative is disclosed in note 14.

There were no transfers between any levels of the fair value hierarchy in the current or prior years.

All shares are equally eligible to receive dividends and the repayment of capital and represent one vote at the shareholders' meeting of the Company.

Share premium account and retained earnings represent balances conventionally attributed to those descriptions. The transaction costs relating to the issue of shares was deducted from share premium.

Capital redemption reserve includes amounts in relation to deferred shared capital.

The Group having no regulatory capital or similar requirements, its primary capital management focus is on maximising earnings per share and therefore shareholder return.

The non-controlling interest reserves arises out of amounts due to holders of the B shares in Acceler8 Ventures Subco Limited.

The Directors have proposed that there will be no final dividend in respect of 2025 (2024: £Nil).

On 27 May 2021, the Group created a Subco Incentive Scheme within its wholly owned subsidiary Acceler8 Ventures Subco Limited ("Subco"). Under the terms of the Subco Incentive Scheme, scheme participants are only rewarded if a predetermined level of shareholder value is created over a three to five year period or upon a change of control of the Company or Subco (whichever occurs first), calculated on a formula basis by reference to the growth in market capitalisation of the Company, following adjustments for the issue of any new Ordinary shares and taking into account dividends and capital returns ("Shareholder Value"), realised by the exercise by the beneficiaries of a put option in respect of their shares in Subco and satisfied either in cash or by the issue of new ordinary shares at the election of the Company.

Under these arrangements in place, participants are entitled to up to 15 per cent. of the Shareholder Value created, subject to such Shareholder Value having increased by at least 12.5 per cent. per annum compounded over a period of between three and five years from admission or following a change of control of the Company or Subco.

As announced on 8 April 2026, the Group intends to void the Subco Incentive Scheme on completion of the Proposed Transaction with no payout to participants.

The Subco Incentive Scheme detailed in note 18 is an equity-settled share option plan which allows employees and advisors of the Group to sell their B shares to the company in exchange for a cash payment or for shares in the Company (at the Company's election) if certain conditions are met.

These conditions include good and bad leaver provisions and that growth in Shareholder Value of 12.5 percent compound per annum is delivered over a three to five year period for the scheme to vest. This second condition is therefore a market condition which has been taken into account in the measurement at grant date of the fair value of the options.

The weighted average exercise price of the outstanding B share options is £Nil which have a weighted average contractual life of 3 years 9 months. 29,000 B share options were issued in the nine-month period to 31 December 2021, all of which were outstanding at the current year end. No B share options were exercised in the current or prior period. No B share options have expired during the current or prior period.

The Group recognised £313 (2024: £314) of expenditure in the statement of total comprehensive income in relation to equity-settled share-based payments in the year.

The fair value of options granted during the period is determined by applying a binominal model. The expense is apportioned over the vesting period of the option and is based on the number which are expected to vest and the fair value of these options at the date of grant.  The inputs into the binomial model in respect of options granted in 2021 are as follows:

Expected volatility was estimated by reference to the average 5-year volatility of the FTSE SmallCap Index.

The target increase in Shareholder Value is laid out in the Articles of Association of the Subco and represents the compounded target annual increase in market capitalisation (adjusted for capital raises and dividends) that needs to be met between the third and fifth anniversary of the Group's admission onto the Main Market of the London Stock Exchange in order for the scheme to vest.

The Group did not enter into any share-based payment transactions with parties other than employees and advisors during the current or prior period.

Below is a reconciliation of non-current liabilities arising from financing activities:

Transactions with key management personnel

Key management personnel comprise the Directors of the Company. The remuneration of the individual Directors is disclosed in the Report of the Directors and Directors' remuneration in note 5.

On 24 March 2025, the Directors each loaned the Company £7,500 for working capital purposes.  On 12 September 2025, the Company repaid each of the Director loans of £7,500.  The loans were interest free.  There are no other outstanding Director loans as at 31 December 2025 (2024: nil).

The ultimate parent company and the smallest and largest group to consolidate these financial statements is Acceler8 Ventures plc.  Balances and transactions between Acceler8 Ventures plc and its subsidiary (listed in note 10), which are related parties, are eliminated on consolidation and are not disclosed in this note. 

Subsequent to the year ended 31 December 2025, on 8 April 2026, the Company announced the Proposed Transaction with IIG.  Under the Proposed Transaction, which if completed, would constitute an initial transaction under UK Listing Rule 13.4 and reverse takeover under the Takeover Code, it is proposed that the enlarged group's shares would be listed on the Equity Shares (Commercial Companies) category of the Official List maintained by the Financial Conduct Authority.  The Proposed Transaction values IIG at approximately £600 million on a fully diluted basis based on the closing price per AC8 share of 80 pence on 7 April 2026.  AC8 shareholders are expected to hold 0.99 per cent. of the enlarged group share capital at admission to trading on the LSE's main market (after the effect of a bonus issue of ordinary shares to AC8 shareholders and the conversion of all outstanding convertible loan notes).

At the date these financial statements were authorised for issue, the Group had not announced a firm offer for IIG under Rule 2.7 of the Takeover Code, and therefore it is not practicable to estimate the financial effect of the Proposed Transaction.

On 21 April 2026, the Company announced that it had successfully raised £1 million through the issue of unsecured convertible loan notes (the "2026 Notes") to support working capital requirements in pursuit of the Proposed Transaction.  The 2026 Notes have an interest rate of 8% per annum that is accrued daily and compounded annually.  Conversion of the 2026 Notes into ordinary shares of the Company is automatic, and immediately prior to completion of an initial transaction or on the third anniversary of issue if no initial transaction occurs.  The conversion price on the basis the Proposed Transaction is completed is 34 pence per share, or where an alternative transaction is completed, a 30% discount to the prevailing share price (initial transaction price or 20-day VWAP at the third anniversary of issue).

At the same time, the Company also announced a proposed amendment to the 2025 Notes to adjust the conversion price per share to 28 pence on the basis the Proposed Transaction completes.

There are no contingent liabilities at the reporting date which would have a material impact on the financial statements.